Financial Highlights Produced 3,863 vehicles in Q2 Delivered 3,309 vehicles in Q2; up 38.2% compared to Q2 2024 Q2 revenue of $259.4 million Q2 GAAP diluted net loss per share of $(0.28); non-GAAP diluted net loss per share of $(0.24) Ended the quarter with approximately $4.86 billion in total liquidity Production outlook for 2025 is revised to 18,000 - 20,000 vehicles from prior guidance of 20,000 vehiclesOperational Highlights Launched next-generation robotaxi partnership that will see Uber deploy a minim ...

Signed 5 deals in the second quarter, highlighted by 3 with new customersPaid down over $300 million on our term loan since separationIntroduced RapidCoolTM, a revolutionary direct-to-chip liquid cooling technology for high performance semiconductors SAN JOSE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) (the “Company” or “Adeia”) today announced financial results for the second quarter ended June 30, 2025. “We delivered revenue of $85.7 million, consistent with our expectations, and ...

SAN FRANCISCO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for its second quarter ended June 30, 2025. Opendoor’s second quarter 2025 financial results and management commentary can be accessed through the Company’s shareholder letter on the “Quarterly Reports” page of Opendoor’s investor relations website at https://investor.opendoor.com/financials-filings/quarterly-repo ...

NASHVILLE, Tenn., Aug. 5, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined net revenues of $10.8 million during the second quarter of 2025, a 10% increase over the prior year period. Year-to-date revenues for the first six months of the year totaled $22.6 million, representing an increase of 23% over the first half of 2024.Cumberland ended the quarter with approximatel ...

First Quarter Revenue Totaled $130.9 Million, Representing Year-over-Year Growth of 11%First Quarter GAAP Net Loss of $14.1 Million and GAAP EPS of ($0.13); First Quarter Non-GAAP Adjusted Net Income1 of $5.8 Million and Non-GAAP Adjusted EPS1 of $0.05First Quarter Non-GAAP Adjusted EBITDA2 Totaled $25.1 Million, Representing Year-over-Year Growth of 73%AUSTIN, Texas, Aug. 5, 2025 /PRNewswire/ -- Digital Turbine, Inc. (Nasdaq: APPS) announced financial results for the fiscal first quarter ended June 30, 202 ...

- Infrastructure: Improved financial flexibility with recent refinancing transactions -- Life Sciences: R2 continuing to see significant year over year growth in system unit sales -- Spectrum: Launched fourth ATSC 3.0 station in collaboration with large mobile carrier - NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- INNOVATE Corp. (“INNOVATE” or the “Company”) (NYSE: VATE) announced today its consolidated results for the second quarter. Financial Summary (in millions, except per share amounts)Three Months End ...

Record high second quarter net revenue of $1.94 billion, up 22% year-over-year and above the high-end of outlook range; up 8% on an organic basis with ADI up 10% and P&S up 5% on an organic basis(1) Total company second quarter gross margin was 29.3%, up 120 basis points year-over-year; Products and Solutions second quarter gross margin was 42.9%, ninth consecutive quarter of year-over-year improvement Second quarter net loss of $825 million, compared to net income of $30 million in the second quarter of 2 ...

LATHAM, N.Y., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Latham Group, Inc., (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground residential pools in North America, Australia, and New Zealand, today announced the appointment of recognized industry executive, Jeffrey J. Jackson, as a new independent member of its Board of Directors and as a member of the Company’s Audit Committee, effective immediately. In connection with Mr. Jackson’s appointment, the size of Latham’s Board has been increase ...

Repowering program advancing with Goat Mountain commercialized for 2027 and Mt. Storm on trackSponsor-enabled growth advancing with 2025/2026 COD program now over 1.6 GW including new offer from Clearway Group to invest in 291 MW Western states storage portfolioThird party acquisitions also continuing with closing of previously announced Catalina Solar projectUpdating 2025 financial guidance range to reflect FY2025 contribution from closed 3rd party acquisitionsIncreasing the quarterly dividend by 1.6% to $ ...

Reported positive interim Phase 1 results for two next-generation TL1A antibodies, demonstrating both were well-tolerated, exhibited pharmacokinetic ("PK") profiles supporting quarterly or biannual dosing, and full TL1A engagement through up to 20 weeks of follow-up Initiated Phase 2 SKYLINE-UC platform study, evaluating three optimized monotherapies and three potentially paradigm-changing combinations in ulcerative colitis ("UC") On track for Q3 initiation of Phase 2 SKYWAY-RD basket study evaluating TL1A ...